SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCoats Group Plc Regulatory News (COA)

Share Price Information for Coats Group Plc (COA)

Share Price is delayed by 15 minutes
Get Live Data
79.95    1.45 (1.85%)
Bid:
79.45
Ask:
79.60
Spread: 0.15 (0.189%)
Market Cap: £1.53b
COA Live PriceLast checked at - London Stock Exchange

Intraday Coats Group Plc Share Chart

Director/PDMR Shareholding

27 Sep 2023 12:32

RNS Number : 8706N
Coats Group PLC
27 September 2023
 

COATS GROUP PLC

LEI: 2138003SPYWGAITNFY17

 

27 September 2023

 

Director/PDMR shareholding

 

Coats Group plc ("Coats" or the "Company"), the world's leading industrial thread and footwear components manufacturer, was notified on 27 September 2023 that Rajiv Sharma, Chief Executive Officer and a Person Discharging Managerial Responsibilities ("PDMR"), acquired and sold ordinary shares of 5 pence each in the Company ("Shares") following the exercise of options, which included the right to dividend equivalents ("Dividend Shares"), granted under the Company's Deferred Annual Bonus Plan ("DABP") as set out below:

 

Date of Grant

Plan

Option Price

Sale Price (£)

Number of Shares acquired

Number of Dividend Shares acquired

Number of Shares sold

Number of Shares retained

28 Feb 2018

DABP

Nil cost share options

0.7405

184,542

6,835

191,377

0

4 March 2019

DABP

Nil cost share options

0.7405

162,044

6,729

168,773

 0

6 March 2020

DABP

Nil cost share options

0.7405

349,640

15,590

365,230

 0

Total

696,226

29,154

725,380

0

 

Following the above transactions, Rajiv's interest in the Company's Shares (excluding outstanding options under the Company's LTIP and DABP) is 4,596,492 Shares. This holding, and the net unvested Deferred Annual Bonus awards that are not subject to performance conditions, fulfils more than twice the requirement to have a minimum shareholding of 200% of basic salary that applies to the Chief Executive under the Company's approved Remuneration Policy.

 

This notification is made in accordance with the requirements of Article 19 of the UK Market Abuse Regulation and the Notification of Dealing Form for the PDMR can be found below.

 

Enquiry details

Investors

Victoria Huxster / Julian Wais

Coats Group plc

+44 (0)7880 471 350

Media

Richard Mountain / Nick Hasell

FTI Consulting

+44 (0)20 3727 1374

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Rajiv Sharma 

b)

Position/status

Chief Executive Officer and Executive Director

c)

Initial notification/ Amendment

Initial notification 

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of entity

Coats Group plc

b)

Legal Entity Identifier Code

2138003SPYWGAITNFY17

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05

b)

Identification code/ ISIN

GB00B4YZN328

c)

Nature of the transaction

Acquisition of Shares resulting from the exercise of options under the Coats Group plc Deferred Annual Bonus Plan (including dividend equivalents)

d)

Price(s) and volume(s)

Price(s)

Volume(s)

Nil

191,377

168,773

365,230

e)

Aggregated information- Aggregated volume- Price

 

725,380

n/a

f)

Date of the transaction

26 September 2023

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

 

1

Details of the person discharging managerial responsibilities/person closely associated

a)

Name

Rajiv Sharma 

b)

Position/status

Chief Executive Officer and Executive Director

c)

Initial notification/ Amendment

Initial notification 

2

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Full name of entity

Coats Group plc

b)

Legal Entity Identifier Code

2138003SPYWGAITNFY17

3

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Ordinary shares of £0.05

b)

Identification code/ ISIN

GB00B4YZN328

c)

Nature of the transaction

Sale of Shares resulting from the exercise of options under the Coats Group plc Deferred Annual Bonus Plan (including dividend equivalents)

d)

Price(s) and volume(s)

Price(s)

Volume(s)

£0.7405

725,380

e)

Aggregated information- Aggregated volume- Price

 

725,380

£537,143.89

f)

Date of the transaction

26 September 2023

g)

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUBOAROAUKUAR
Date   Source Headline
8th Jun 20269:23 amRNSHolding(s) in Company
20th May 20264:16 pmRNSResult of AGM
20th May 20267:00 amRNSTrading Statement
14th May 202611:00 amRNSAppointment of Chair
6th May 202611:00 amRNSDirectorate change
24th Apr 20261:15 pmRNSHolding(s) in Company
8th Apr 202611:00 amRNSDirector Declaration
30th Mar 202611:15 amRNSDirector/PDMR Shareholding
24th Mar 202611:08 amRNSHolding(s) in Company
17th Mar 20262:07 pmRNSDirector/PDMR Shareholding
12th Mar 202610:03 amRNSAnnual Financial Report
12th Mar 202610:03 amRNSAnnual Financial Report
5th Mar 20267:00 amRNS2025 Full Year Results
11th Feb 202611:00 amRNSChanges to Director's Responsibilities
9th Feb 20262:07 pmRNSHolding(s) in Company
6th Feb 20262:00 pmRNSDirector Declaration
17th Dec 20252:00 pmRNSDirector/PDMR Shareholding
7th Nov 20257:00 amRNSTrading Statement
5th Nov 20252:45 pmRNSDirector Declaration
30th Oct 20257:00 amRNSCompletion of OrthoLite acquisition
20th Oct 202512:41 pmRNSDirector/PDMR Shareholding
17th Oct 20251:42 pmRNSHolding(s) in Company
6th Oct 20251:06 pmRNSBlock listing Interim Review
16th Sep 20252:00 pmRNSDirector Declaration
12th Sep 20253:22 pmRNSHolding(s) in Company
11th Sep 20253:13 pmRNSHolding(s) in Company
10th Sep 20251:09 pmRNSDirector/PDMR Shareholding
3rd Sep 202512:58 pmRNSHolding(s) in Company
11th Aug 202511:03 amRNSHolding(s) in Company
5th Aug 202510:44 amRNSHolding(s) in Company
31st Jul 202512:39 pmRNSTotal Voting Rights
29th Jul 20257:00 amRNSFurther Information re Acquisition of OrthoLite
23rd Jul 20259:26 amRNSHolding(s) in Company
22nd Jul 202510:31 amRNSHolding(s) in Company
21st Jul 20253:25 pmRNSDirector/PDMR Shareholding
21st Jul 20252:30 pmRNSHolding(s) in Company
21st Jul 20252:27 pmRNSHolding(s) in Company
17th Jul 20256:00 pmRNSCoats Group
17th Jul 20257:00 amRNSResults of Capital Raise
16th Jul 20255:47 pmRNSAcquisition - Retail Offer Launch (Replacement)
16th Jul 20254:50 pmRNSAcquisition - Retail Offer Launch
16th Jul 20254:46 pmRNSAcquisition - Capital Raise Launch
16th Jul 20254:45 pmRNSHalf-year Report
16th Jul 20254:45 pmRNSAcquisition
27th Jun 20251:06 pmRNSHolding(s) in Company
24th Jun 20257:00 amRNSDirectorate Change
4th Jun 20251:42 pmRNSDirector/PDMR Shareholding
23rd May 202511:32 amRNSDirector/PDMR Shareholding
21st May 20253:58 pmRNSResult of AGM
21st May 20257:00 amRNSTrading Statement

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.